Items where authors include "Gerding, DN"

Article

Goldstein, EJC, Citron, DM, Gerding, DN et al. (5 more authors) (2020) Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY II. Clinical Infectious Diseases, 71 (4). ciz1151. pp. 1102-1105. ISSN 1058-4838

Kelly, CP, Poxton, IR, Shen, J et al. (7 more authors) (2020) Effect of Endogenous Clostridioides difficile Toxin Antibodies on Recurrence of C. difficile Infection. Clinical Infectious Diseases, 71 (1). pp. 81-86. ISSN 1058-4838

Gerding, DN, Cornely, OA, Grill, S et al. (11 more authors) (2019) Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials. The Lancet Infectious Diseases, 19 (3). pp. 265-274. ISSN 1473-3099

Kociolek, LK, Perdue, ER, Fawley, WN et al. (3 more authors) (2018) Correlation between restriction endonuclease analysis and PCR ribotyping for the identification of Clostridioides (Clostridium) difficile clinical strains. Anaerobe, 54. pp. 1-7. ISSN 1075-9964

McDonald, LC, Gerding, DN, Johnson, S et al. (11 more authors) (2018) Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clinical Infectious Diseases, 66 (7). pp. 987-994. ISSN 1058-4838

McDonald, LC, Gerding, DN, Johnson, S et al. (11 more authors) (2018) Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clinical Infectious Diseases, 66 (7). e1-e48. ISSN 1058-4838

Vickers, RJ, Tillotson, GS, Nathan, R et al. (41 more authors) (2017) Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study. The Lancet Infectious Diseases, 17 (7). pp. 735-744. ISSN 1473-3099

Wilcox, MH orcid.org/0000-0002-4565-2868, Gerding, DN, Poxton, IR et al. (18 more authors) (2017) Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. New England Journal of Medicine, 376 (4). pp. 305-317. ISSN 0028-4793

Bauer, MP, Hensgens, MPM, Miller, MA et al. (6 more authors) (2012) Renal failure and leukocytosis are predictors of a complicated course of clostridium difficile infection if measured on day of diagnosis. Clinical Infectious Diseases, 55 (Supplement 2). S149-S153. ISSN 1058-4838